- Home
- PZG vs NSPR Comparison
PZG vs NSPR Comparison
Compare PZG & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PZG
- NSPR
- Stock Information
- Founded
- PZG 1992
- NSPR 2005
- Country
- PZG United States
- NSPR United States
- Employees
- PZG N/A
- NSPR N/A
- Industry
- PZG Metal Mining
- NSPR Medical/Dental Instruments
- Sector
- PZG Basic Materials
- NSPR Health Care
- Exchange
- PZG Nasdaq
- NSPR Nasdaq
- Market Cap
- PZG 98.5M
- NSPR 99.7M
- IPO Year
- PZG 1999
- NSPR N/A
- Fundamental
- Price
- PZG $1.22
- NSPR $2.42
- Analyst Decision
- PZG
- NSPR Strong Buy
- Analyst Count
- PZG 0
- NSPR 2
- Target Price
- PZG N/A
- NSPR $4.50
- AVG Volume (30 Days)
- PZG 633.7K
- NSPR 119.2K
- Earning Date
- PZG 11-11-2025
- NSPR 11-11-2025
- Dividend Yield
- PZG N/A
- NSPR N/A
- EPS Growth
- PZG N/A
- NSPR N/A
- EPS
- PZG N/A
- NSPR N/A
- Revenue
- PZG N/A
- NSPR $7,066,000.00
- Revenue This Year
- PZG N/A
- NSPR $7.48
- Revenue Next Year
- PZG N/A
- NSPR $104.39
- P/E Ratio
- PZG N/A
- NSPR N/A
- Revenue Growth
- PZG N/A
- NSPR 7.60
- 52 Week Low
- PZG $0.31
- NSPR $1.99
- 52 Week High
- PZG $1.41
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- PZG 62.84
- NSPR 50.48
- Support Level
- PZG $1.15
- NSPR $2.38
- Resistance Level
- PZG $1.27
- NSPR $2.57
- Average True Range (ATR)
- PZG 0.08
- NSPR 0.07
- MACD
- PZG -0.01
- NSPR 0.01
- Stochastic Oscillator
- PZG 47.68
- NSPR 36.51
About PZG Paramount Gold Nevada Corp.
Paramount Gold Nevada Corp is an exploration-stage mining company. Together with its subsidiaries, the company is engaged in the business of acquiring, exploring, and developing precious metal projects in the United States. Also, it explores for gold and silver. The company enhances the value of projects by implementing exploration and engineering programs that are likely to expand and upgrade known mineralized material to reserves. Its projects include sleeper gold, grassy mountain gold, frost project, other non-material, and others.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.